The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to Fibroblast Growth Factor Receptor 1

Blood

Volumn 93, Issue 4, 1999, Pages 1381-1389

  Popovici, Cornel ^b   Zhang, Bin ^b   Grégoire, Marie José ^b   Jonveaux, Philippe ^b   Lafage Pochitaloff, Marina ^b   Birnbaum, Daniel ^b   Pébusque, Marie Josèphe ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 8; GENE FUSION; HUMAN; HUMAN CELL; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

EID: 0033558253     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1381.404k30_1381_1389     Document Type: Article

References (49)

1. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
2. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77:171, 1994
3. Solomon E, Borrow J, Goddard AD: Chromosome aberrations and cancer. Science 254:1153, 1991
4. Drexler HG, MacLeod RA, Borkhardt A, Janssen JW: Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 9:480, 1995
5. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417, 1997
6. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC: A new proliferative disorder associated with chromosomal translocations involving 8p11: A review. Leukemia 9:1628, 1995
7. Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM, Cross NC: Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 90:3130, 1997
8. Still IH, Chernova O, Hurd D, Stone RM, Cowell JK: Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: Evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood 90:3136, 1997
9. Heim S, Avanzi GC, Billstrom R, Kristoffersson U, Mandahl N, Bekassy AN, Garwicz S, Wiebe T, Pegoraro L, Falda M, Resegotti L, Mitelman F: A new specific chromosomal rearrangement, 1(8:16) (p11;p13), in acute monocytic leukaemia. Br J Haematol 66:323, 1987
10. Slovak ML, Nemana L, Traweek ST, Stroh JA: Acute monoblastic leukemia (FAB-M5b) with t(8:14)(p11;q11.1). Cancer Genet Cytogenet 56:237, 1991
11. Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, Stein J, Yaniv I, Barak Y, Zaizov R: A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11; q13); case report and review of the literature. Leuk Res 19:367, 1995
12. Lai JL, Zandecki M, Fenaux P, Preudhomme C, Facon T, Deminatti M: Acute monocytic leukemia with (8;22)(p11:q13) translocation. Involvement of 8p11 as in classical t(8;16)(p11;p13). Cancer Genet Cytogenet 60:180, 1992
13. Soenen V, Chaffanet M, Preudhomme C, Dib A, Lai JL, Fletcher JA, Birnbaum D, Pebusque MJ: Identification of a YAC spanning the translocation breakpoint t(8:22) associated with acute monocytic leukemia. Genes Chromosom Cancer 15:191, 1996
14. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE: The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14:33, 1996
15. Carapeti M, Aguiar RC, Goldman JM, Cross NC: A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91:3127, 1998
16. Chaffanet M, Popovici C, Leroux D, Jacrot M, Adélaïde J, Dastugue N, Grégoire M-J, Lafage Pochitaloff M, Birnbaum D, Pébusque M-J: t(6;8), t(8;9) and t(8;13) translocations associated with myeloproliferative disorders have close or identical breakpoints on chromosome 8p11-12. Oncogene 16:945, 1998
17. Johnson DE, Lu J, Chen H, Werner S, Williams LT: The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627, 1991
18. Popovici C, Adélaïde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pébusque M-J: Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Proc Natl Acad Sci USA 95:5712, 1998
19. Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C, Shipley J: The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet 7:637, 1998
20. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA: FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet 18:84, 1998
21. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Goncalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC: Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 92:1735, 1998
22. Still IH, Cowell JK: The t(8;13) atypical myeloproliferative disorder: Further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. Blood 92:1456, 1998
23. Vannier JP, Bizet M, Bastard C, Bernard A, Ducastelle T, Tron P: Simultaneous occurrence of a T-cell lymphoma and a chronic myelogenous leukemia with an unusual karyotype. Leuk Res 8:647, 1984
24. Elsner S, Martin H, Rode C, Wassman B, Ganser A, Hoelzer D: An uncommon chromosomal translocation t(6;8) associated with atypical acute myelogenous leukemia/myeloproliferative disease detected by fluorescence in situ hybridisation. Br J Haematol 87:124, 1994
25. Birg F, Courcoul M, Rosnet O, Bardin F, Pébusque M-J, Marchetto S, Tabilio A, Mannoni P, Birnbaum D: Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80:2584, 1992
26. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403, 1990
27. Gish W, States D: Identification of protein coding regions by database similarity search. Nat Genet 3:266, 1993
28. Corpet F: Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16:10881, 1988
29. Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA: Splicing of messenger RNA precursors. Annu Rev Biochem 55:1119, 1986
30. Gamier J, Gibrat JF, Robson B: GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 266:540, 1996
31. Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R: Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 52:2004, 1992
32. Allouche M, Bayard F, Clamens S, Fillola G, Sie P, Amalric F: Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 9:77, 1995
33. Hou JZ, Kan MK, McKeehan K, McBride G, Adams P, McKeehan WL: Fibroblast growth factor receptors from liver vary in three structural domains. Science 251:665, 1991
34. Twigg SR, Burns HD, Oldridge M, Heath JK, Wilkie AO: Conserved use of a non-canonical 5' splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3. Hum Mol Genet 7:685, 1998
35. Kobe B, Deisenhofer J: The leucine-rich repeat: A versatile binding motif. Trends Biochem Sci 19:415, 1994
36. Kajava AV: Structural diversity of leucin-rich repeat proteins. J Mol Biol 277:519, 1998
37. Mason IJ: The ins and outs of fibroblast growth factors. Cell 78:547, 1994
38. Goldfarb M: Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7:311, 1996
39. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8:269, 1994
40. Lorenzi MV, Horii Y, Yamanaka R, Sakaguchi K, Miki T: FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Proc Natl Acad Sci USA 93:8956, 1996
41. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
42. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D, Theillet C: BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6:659, 1991
43. Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P, Gaudray P, Birnbaum D: FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosom Cancer 7:219, 1993
44. Dib A, Adélaïde J, Chaffanet M, Imbert A, Le Paslier D, Jacquemier J, Gaudray P, Theillet C, Birnbaum D, Pébusque M-J: Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene 10:995, 1995
45. Adélaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale AL, Lidereau R, Birnbaum D, Pébusque M-J: Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancer. Genes Chromosom Cancer 22:186, 1998
46. Barr FG: Translocations, cancer and the puzzle of specificity. Nat Genet 19:121, 1998
47. Le Bousse-Kerdiles MC, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyre MC: Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88:4534, 1996
48. Dickstein JI, Vardiman JW: Hematopathologic findings in the myeloproliferative disorders. Semin Oncol 22:355, 1995
49. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J: Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9:2685, 1990